1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow bexmarilimab: new trials by email Literature Review of bexmarilimab trials Research Report on bexmarilimab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate Safety, Tolerability and Preliminary Efficacy of FP-1305 in Cancer Patients (MATINS) FP-1305 (bexmarilimab) - Cancer | Phase 1 / Phase 2 | Completed | Faron Pharmaceuticals Ltd | 216 | 2018-12-03 | 2025-04-02 |
Neoplasms (1)
Finland (1) · France (1) · Netherlands (1) · Spain (1) · United Kingdom (1) · United States (1)
PMID 34078651, PMID 35500016, PMID 38056464
2018 (1)